OPTASE- glycerin solution/ drops

Optase by

Drug Labeling and Warnings

Optase by is a Otc medication manufactured, distributed, or labeled by Scope Health Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children.
If swallowed get medical
help or contact a poison
control center right away.

ACTIVE INGREDIENT

0.3 % glycerin

PURPOSE

Eye Lubricant

INACTIVE INGREDIENT

Inactive Ingredients
Borax, Boric Acid, Citric Acid anhydrous,
Sodium Chloride, Sodium Citrate Dihydrate, Sodium Hyaluronate, water.

DOSAGE & ADMINISTRATION

Directions:
Put one or two drops in the
affected eyes as needed.

WARNINGS

Warning
■ For external use only.
■ If solution changes color or becomes cloudy, do not use.
■ To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
Stop use and ask doctor if
■ You feel eye pain.
■ Changes in vision occur.
■ Redness or irritation of the eye lasts.
■ Condition worsens or lasts more than 72 hours.

INDICATIONS & USAGE

Uses
For use as a lubricant to prevent
further irritation.
May be used as a protectant against
further irritation.
To relieve dryness of the eye.

Immediate Label

Optase Hylo - Full Label

INGREDIENTS AND APPEARANCE

OPTASE 
glycerin solution/ drops

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72972-008
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)	GLYCERIN	0.3 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
SODIUM BORATE (UNII: 91MBZ8H3QO)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
BORIC ACID (UNII: R57ZHV85D4)
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72972-008-01	1 in 1 BOX	06/13/2025
1		10 mL in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M018	06/13/2025

Labeler - Scope Health Inc (116778693)